These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34644796)

  • 1. [Aspirin in primary prevention of cardiovascular and cerebrovascular diseases].
    Gassanov N; Eicke M; Er F
    Dtsch Med Wochenschr; 2021 Oct; 146(20):1353-1359. PubMed ID: 34644796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases].
    Landmark K
    Tidsskr Nor Laegeforen; 1997 Dec; 117(30):4432-6. PubMed ID: 9456592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice.
    Battistoni A; Mastromarino V; Volpe M
    Clin Cardiol; 2015 Jun; 38(6):387-94. PubMed ID: 25873555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
    Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
    G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for the primary prevention of cardiovascular disease: a comprehensive review.
    Rodondi N; Cornuz J; Bauer DC
    Compr Ther; 2005; 31(3):186-93. PubMed ID: 16110127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of hemorrhagic stroke with aspirin use: an update.
    Gorelick PB; Weisman SM
    Stroke; 2005 Aug; 36(8):1801-7. PubMed ID: 16020759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective.
    Rocca B; Patrono C
    Diabetes Res Clin Pract; 2020 Feb; 160():108008. PubMed ID: 31926190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for primary prevention of cardiovascular disease in patients with diabetes: A meta-analysis.
    Kokoska LA; Wilhelm SM; Garwood CL; Berlie HD
    Diabetes Res Clin Pract; 2016 Oct; 120():31-9. PubMed ID: 27500549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea.
    Jung M; Lee S
    Drugs Aging; 2020 Jan; 37(1):43-55. PubMed ID: 31755069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment of asymptomatic carotid atherosclerosis: a medical dilemma.
    Gresele P; Paciullo F; Migliacci R
    Intern Emerg Med; 2020 Oct; 15(7):1169-1181. PubMed ID: 32405817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin and prevention of cardiovascular risk].
    Karila-Cohen D; Gabriel Steg P
    Rev Med Interne; 2000 Mar; 21 Suppl 1():35s-40s. PubMed ID: 10763203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin resistance.
    Hankey GJ; Eikelboom JW
    Lancet; 2006 Feb; 367(9510):606-17. PubMed ID: 16488805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin in the Prevention of Cardiovascular Disease and Cancer.
    Ricciotti E; FitzGerald GA
    Annu Rev Med; 2021 Jan; 72():473-495. PubMed ID: 33502899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
    Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases.
    Fasano S; Iacono D; Riccardi A; Ciccia F; Valentini G
    Rheumatology (Oxford); 2020 Dec; 59(12):3593-3602. PubMed ID: 32830272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events.
    Weisman SM; Graham DY
    Arch Intern Med; 2002 Oct; 162(19):2197-202. PubMed ID: 12390062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.